OncoType Dx: Prediciendo la Recurrencia del Cáncer

This article has been moved to a new location
View article


Where Are the Adults in the Room?
by Rodney Warner, JD
November 20, 2015

Related News

FDA Approves Keytruda for Advanced NSCLC

Oct 5, 2015

Approved for use with PD-L1 IHC 22C3 pharmDx test

High False-Negative Rate for HER2 Status Using Oncotype DX

Oct 13, 2011

HER2 status in breast cancer with RT-PCR assay is discordant with IHC/FISH results


Aug 31, 2010